Peter L. Jones

4.7k total citations
64 papers, 3.6k citations indexed

About

Peter L. Jones is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Peter L. Jones has authored 64 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 15 papers in Genetics and 9 papers in Genetics. Recurrent topics in Peter L. Jones's work include Muscle Physiology and Disorders (33 papers), Neurogenetic and Muscular Disorders Research (9 papers) and RNA modifications and cancer (9 papers). Peter L. Jones is often cited by papers focused on Muscle Physiology and Disorders (33 papers), Neurogenetic and Muscular Disorders Research (9 papers) and RNA modifications and cancer (9 papers). Peter L. Jones collaborates with scholars based in United States, Australia and Netherlands. Peter L. Jones's co-authors include Paul A. Wade, Takako I. Jones, Alan P. Wolffe, Jeremy M. Boss, Dongsheng Ping, Charis L. Himeda, Danielle Vermaak, Yun‐Bo Shi, Ryan D. Wuebbles and Bruce D. Sidell and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Peter L. Jones

63 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter L. Jones United States 34 2.6k 763 348 294 267 64 3.6k
Hanka Venselaar Netherlands 32 2.1k 0.8× 799 1.0× 166 0.5× 86 0.3× 177 0.7× 87 3.4k
James E. Sylvester United States 30 2.4k 0.9× 745 1.0× 275 0.8× 289 1.0× 133 0.5× 53 3.5k
Colette Rossier Switzerland 35 2.6k 1.0× 1.1k 1.5× 121 0.3× 116 0.4× 199 0.7× 62 4.8k
Marilena Cipollaro Italy 31 1.4k 0.5× 366 0.5× 527 1.5× 217 0.7× 203 0.8× 103 2.8k
Patrick Page-McCaw United States 23 4.2k 1.6× 980 1.3× 181 0.5× 155 0.5× 701 2.6× 32 5.4k
Marcia L. Budarf United States 34 2.9k 1.1× 1.5k 2.0× 212 0.6× 101 0.3× 281 1.1× 72 4.0k
Jeffrey Rosenfeld United States 25 2.8k 1.1× 619 0.8× 122 0.4× 143 0.5× 331 1.2× 52 3.7k
Michael R. Altherr United States 32 2.5k 1.0× 1.3k 1.6× 187 0.5× 227 0.8× 117 0.4× 65 3.4k
Stéphanie Le Gras France 32 2.0k 0.8× 437 0.6× 108 0.3× 91 0.3× 443 1.7× 57 2.9k
Jing-Ruey Joanna Yeh United States 28 4.8k 1.8× 1.1k 1.4× 85 0.2× 134 0.5× 342 1.3× 48 5.9k

Countries citing papers authored by Peter L. Jones

Since Specialization
Citations

This map shows the geographic impact of Peter L. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter L. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter L. Jones more than expected).

Fields of papers citing papers by Peter L. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter L. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter L. Jones. The network helps show where Peter L. Jones may publish in the future.

Co-authorship network of co-authors of Peter L. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Peter L. Jones. A scholar is included among the top collaborators of Peter L. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter L. Jones. Peter L. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Himeda, Charis L., Takako I. Jones, & Peter L. Jones. (2025). All-in-one vectors for epigenetic CRISPR inhibition of DUX4-fl in facioscapulohumeral muscular dystrophy. Molecular Therapy — Methods & Clinical Development. 33(3). 101546–101546.
2.
Himeda, Charis L., Takako I. Jones, & Peter L. Jones. (2024). Have a Little Heart (or Not): Highly Minimized Skeletal Muscle Regulatory Cassettes with Low or No Activity in the Heart. Human Gene Therapy. 35(15-16). 543–554. 2 indexed citations
3.
Wong, Chao-Jen, Seth D. Friedman, Lauren Snider, et al.. (2024). Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression. Human Molecular Genetics. 33(8). 698–708. 10 indexed citations
4.
Nunes, Andreia M., et al.. (2024). Muscle eosinophilia is a hallmark of chronic disease in facioscapulohumeral muscular dystrophy. Human Molecular Genetics. 33(10). 872–883. 1 indexed citations
5.
Lim, Kenji Rowel Q., Rika Maruyama, Yusuke Echigoya, et al.. (2020). Inhibition of DUX4 expression with antisense LNA gapmers as a therapy for facioscapulohumeral muscular dystrophy. Proceedings of the National Academy of Sciences. 117(28). 16509–16515. 43 indexed citations
6.
Lek, Angela, Tracy Zhang, Keryn G. Woodman, et al.. (2020). Applying genome-wide CRISPR-Cas9 screens for therapeutic discovery in facioscapulohumeral muscular dystrophy. Science Translational Medicine. 12(536). 45 indexed citations
7.
Himeda, Charis L., Takako I. Jones, & Peter L. Jones. (2020). Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD. Molecular Therapy — Methods & Clinical Development. 20. 298–311. 41 indexed citations
8.
Webster, Graham R., et al.. (2018). Tristearin as a Model Cuticle for High-Throughput Screening of Agricultural Adjuvant Systems. ACS Omega. 3(12). 16672–16680. 3 indexed citations
9.
Jones, Takako I., et al.. (2016). Large family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy. Neuromuscular Disorders. 27(3). 221–238. 18 indexed citations
10.
Himeda, Charis L., Takako I. Jones, & Peter L. Jones. (2014). Facioscapulohumeral Muscular Dystrophy As a Model for Epigenetic Regulation and Disease. Antioxidants and Redox Signaling. 22(16). 1463–1482. 28 indexed citations
11.
Jones, Takako I., Jennifer C. J. Chen, Fedik Rahimov, et al.. (2012). Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Human Molecular Genetics. 21(20). 4419–4430. 139 indexed citations
12.
Koningsbruggen, Silvana van, Kirsten R. Straasheijm, Rinse Klooster, et al.. (2011). Facioscapulohumeral Muscular Dystrophy Region Gene 1 Is a Dynamic RNA-Associated and Actin-Bundling Protein. Journal of Molecular Biology. 411(2). 397–416. 22 indexed citations
13.
Wuebbles, Ryan D., et al.. (2008). Muscular dystrophy candidate gene FRG1 is critical for muscle development. Developmental Dynamics. 238(6). 1502–1512. 42 indexed citations
14.
El‐Osta, Assam, Daniella Brasacchio, Dachun Yao, et al.. (2008). Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. The Journal of Experimental Medicine. 205(11). 2683–2683. 36 indexed citations
15.
Harikrishnan, K N, Maggie Zi Ying Chow, Emma K. Baker, et al.. (2005). Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nature Genetics. 37(3). 254–264. 238 indexed citations
16.
Stünkel, Walter, Slimane Ait‐Si‐Ali, Peter L. Jones, & Alan P. Wolffe. (2001). Programming the Transcriptional State of Replicating Methylated DNA. Journal of Biological Chemistry. 276(23). 20743–20749. 3 indexed citations
17.
Wade, Paul A., Peter L. Jones, Danielle Vermaak, & Alan P. Wolffe. (1998). A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase. Current Biology. 8(14). 843–848. 356 indexed citations
18.
Jones, Peter L., Dongsheng Ping, & Jeremy M. Boss. (1997). Tumor Necrosis Factor Alpha and Interleukin-1β Regulate the Murine Manganese Superoxide Dismutase Gene Through a Complex Intronic Enhancer Involving C/EBP-β and NF-κB. Molecular and Cellular Biology. 17(12). 6970–6981. 212 indexed citations
19.
Ping, Dongsheng, Peter L. Jones, & Jeremy M. Boss. (1996). TNF Regulates the In Vivo Occupancy of Both Distal and Proximal Regulatory Regions of the MCP-1/JE Gene. Immunity. 4(5). 455–469. 117 indexed citations
20.
Berntorp, Erik, Victor Boulyjenkov, Doreen B. Brettler, et al.. (1995). Modern treatment of haemophilia.. PubMed. 73(5). 691–701. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hanka Venselaar Breakdown of academic impact, for papers by James E. Sylvester Breakdown of academic impact, for papers by Colette Rossier Breakdown of academic impact, for papers by Marilena Cipollaro Breakdown of academic impact, for papers by Patrick Page-McCaw Breakdown of academic impact, for papers by Marcia L. Budarf Breakdown of academic impact, for papers by Jeffrey Rosenfeld Breakdown of academic impact, for papers by Michael R. Altherr Breakdown of academic impact, for papers by Stéphanie Le Gras Breakdown of academic impact, for papers by Jing-Ruey Joanna Yeh
Rankless by CCL
2026